Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02654756 · ClinicalTrials.gov registry record
Risk of Chronic Kidney Disease Progression
A clinical trial, sponsored by Winthrop University Hospital.
- Completed
- Registry status
- 623
- Enrollment target
NCT02654756: Completed study, sponsored by Winthrop University Hospital.
NCT02654756 is a clinical trial that has completed, run by Winthrop University Hospital. The registered enrollment target is 623 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02654756 has completed, sponsored by Winthrop University Hospital.
- COMPLETED
- Registry status
- 623 participants
- Enrollment target
Study Summary
While there are proven therapies that slow CKD progression, these therapies can at times be harmful and costly. The ability to accurately predict the risk of CKD progression to ESRD would be extremely valuable. The short term versus lifetime risk of CKD progression should be taken into account when making risk based clinical decisions. In a representative CKD practice, the investigators compared the short term and lifetime risk assessment in our stage 3 CKD patients to determine whether decisions based on a short term risk assessment would underestimate the lifetime risk of CKD progression. The investigators also applied the short term risk assessment to our stage 4 CKD patients to determine the frequency with which ESRD risk may be overestimated in CKD stage 4.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 623 participants |
| Start Date | 2013-05 |
| Est. Completion | 2018-11 |
What the finished NCT02654756 record still lists
NCT02654756 is an observational study that tracks outcomes without assigning an intervention. The registered 623 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02654756 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02654756 about?
NCT02654756 is a clinical study titled "Risk of Chronic Kidney Disease Progression". While there are proven therapies that slow CKD progression, these therapies can at times be harmful and costly. The ability to accurately predict the risk of CKD progression to ESRD would be extremely valuable. The short term versus lifetime risk of CKD progression should be taken into account when ...
What is the current status of trial NCT02654756?
This trial is currently completed. The enrollment target is 623 participants. The study started on 2013-05. Estimated completion is 2018-11.
Who is sponsoring clinical trial NCT02654756?
This trial is sponsored by Winthrop University Hospital, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06406049 · 624 participants · NA
Finishing HIV Project
- NCT05349227 · 625 participants · NA
Comprehensive Outcomes for After Cancer Health
- NCT06103864 · 625 participants · Phase 3
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer
- NCT06230510 · 625 participants · NA
Milk-Tot Study: Impact of Whole Versus Low-fat Milk on Child Health
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia